Related Experiment Videos
Aging and cancer: issues of basic and clinical science
1Glennan Center for Geriatrics and Gerontology, Eastern Virginia Medical School, Norfolk, USA.
Journal of the National Cancer Institute
|October 23, 1997
Summary
Cancer and aging research is crucial, especially since most cancer patients are over 70. More investigation into how aging impacts cancer development, progression, and treatment is urgently needed.
Area of Science:
- Geriatric Medicine
- Biogerontology
- Oncology
Background:
- Most cancer patients in the United States are over 70 years old.
- The molecular overlap between oncogenesis and aging is under-researched.
- There's a growing need to understand how host age influences tumor development, progression, and treatment outcomes.
Purpose of the Study:
- To frame key questions regarding the intersection of cancer and aging.
- To highlight the importance of biogerontology and geriatric medicine perspectives.
- To emphasize the critical need for increased research efforts in aging and cancer.
Main Methods:
- Literature review and synthesis.
- Framing research questions from biogerontological and geriatric medicine viewpoints.
- Identifying knowledge gaps in the field of cancer and aging.
Main Results:
- The molecular interplay between aging and cancer remains largely unexplored.
- Clinical understanding of age's impact on cancer is insufficient.
- A comprehensive approach integrating aging research is essential for advancing cancer care.
Conclusions:
- Addressing the complexities of aging in cancer patients is paramount.
- Further research is vital to improve cancer treatment and outcomes for older adults.
- Integrating biogerontology and geriatric medicine is key to future cancer research.